Nemaura Medical Inc. (NMRD) Misses Q2 EPS by 3c

Nemaura Medical Inc. (NASDAQ: NMRD) reported Q2 EPS of ($0.17), $0.03 worse than the analyst estimate of ($0.14).

For earnings history and earnings-related data on Nemaura Medical Inc. (NMRD) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Energy Fuels to acquire rare earth magnet maker VAC for $1.9 billion
• Bernstein SocGen Group Upgrades X-Fab Silicon Foundries SE (XFAB:FP) to Outperform